Type 2 & other diabetes

Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects

Diabetes Obes MetabPublished Prospective cohort study

Main finding · Composite endpointResult — go to the resultHazard ratio 1.97 95% CI 1.47–2.65

Authors' conclusion

The findings highlight the synergistic impact of diabetes and HHcy on CVD. Joint assessments of diabetes and Hcy levels should be emphasized for risk stratification and primary prevention of CVD.

Study context

Population
Adults in northern China, Asymptomatic Polyvascular Abnomalities Community study, 2010–2019; mean age 55.1 years, 60% male
Participants
5,278 adults
Exposure
Diabetes/HHcy vs non-diabetes/non-HHcy
Outcome
Composite of:
  • First-ever stroke
  • MI
  • All-cause mortality
Follow-up
9.1 years
Methodological detailscommunity-based
  • Community-based

Main finding

Composite endpoint

Hazard ratio

1.97

95% CI 1.47–2.65

Diabetes/HHcyvs Non-diabetes/non-HHcy
HR 1.97 (95% CI 1.47–2.65)

As reported in the abstract

Events (202 stroke, 52 myocardial infraction (MI), 406 all-cause deaths)
618

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
StrokeDiabetes/HHcyvs Non-diabetes/non-HHcyInteraction HHcy × diabetes1.85 (1.12–3.04)P for interaction = 0.002
MIDiabetes/HHcyvs Non-diabetes/non-HHcyInteraction HHcy × diabetes1.33 (0.42–4.23)P for interaction = 0.027
MACEDiabetes/HHcyvs Non-diabetes/non-HHcyInteraction HHcy × diabetes1.78 (1.13–2.80)P for interaction = 0.044
All-cause deathDiabetes/HHcyvs Non-diabetes/non-HHcy2.24 (1.56–3.23)
Stroke — Diabetes/HHcy–stroke association modified by age (<60 vs ≥60 years); P for interaction
.016

Original publication

Synergies between diabetes and hyperhomocysteinaemia: New insights to predict and prevent adverse cardiovascular effects. Diabetes Obes Metab. Published 21 October 2024. doi:10.1111/dom.15947

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.